Metastatic breast cancer correlates with poor clinicopathological phenotype of invasion and drug resistance, downregulation of FBXW7 expression attenuates the ubiquitination and destruction of associated substrates, hence boosting breast cancer invasion and metastasis [18, 25, 95, 96] (Fig. 5C). This evidence concerns the gene FBXW7 and breast carcinoma.